GABA transaminase inhibitor

This page covers all GABA transaminase inhibitor drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting GABA transaminase (ABAT).

Targets

GABA transaminase (ABAT)

Marketed (1)

• Sabril® · Lundbeck LLC · Neurology
  Sabril (vigabatrin) irreversibly inhibits GABA transaminase, the enzyme that breaks down the neurotransmitter GABA, thereby increasing GABA levels in the brain.

Patent intelligence

• gaba transaminase inhibitor patent landscape — aggregated cliff calendar, attackable patents, originator estates